Quick Answer
GSK plc reported Gross Profit of $23.65 billion for fiscal year 2025.
GSK plc Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $23.65B | +5.9% |
| 2024 | $22.33B | +2.6% |
| 2023 | $21.76B | +10.1% |
| 2022 | $19.77B | +19.6% |
| 2021 | $16.53B | +0.7% |
| 2020 | $16.43B | -25.0% |
| 2019 | $21.89B | +6.4% |
| 2018 | $20.58B | +3.7% |
| 2017 | $19.84B | +6.7% |
| 2016 | $18.60B | — |
- GSK plc showed an increase of +5.9% in Gross Profit compared to the prior fiscal year.
- Over the 2016–2025 period, GSK plc’s gross profit has grown by 27.2% (from $18.60 billion to $23.65 billion).
- The most recent figure is from GSK plc’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: